<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39321553</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-4331</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Sep</Month><Day>26</Day></PubDate></JournalIssue><Title>Clinical chemistry and laboratory medicine</Title><ISOAbbreviation>Clin Chem Lab Med</ISOAbbreviation></Journal><ArticleTitle>Targeted MRM-analysis of plasma proteins in frozen whole blood samples from patients with COVID-19: a retrospective study.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1515/cclm-2024-0800</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The COVID-19 pandemic has exposed a number of key challenges that need to be urgently addressed. Mass spectrometric studies of blood plasma proteomics provide a deep understanding of the relationship between the severe course of infection and activation of specific pathophysiological pathways. Analysis of plasma proteins in whole blood may also be relevant for the pandemic as it requires minimal sample preparation.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The frozen whole blood samples were used to analyze 203 plasma proteins using multiple reaction monitoring (MRM) mass spectrometry and stable isotope-labeled peptide standards (SIS). A total of 131 samples (FRCC, Russia) from patients with mild (n=41), moderate (n=39) and severe (n=19) COVID-19 infection and healthy controls (n=32) were analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Levels of 94 proteins were quantified and compared. Significant differences between all of the groups were revealed for 44 proteins. Changes in the levels of 61 reproducible COVID-19 markers (SERPINA3, SERPING1, ORM1, HRG, LBP, APOA1, AHSG, AFM, ITIH2, etc.) were consistent with studies performed with serum/plasma samples. The best-performing classifier built with 10 proteins achieved the best combination of ROC-AUC (0.97-0.98) and accuracy (0.90-0.93) metrics and distinguished patients from controls, as well as patients by severity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Here, for the first time, frozen whole blood samples were used for proteomic analysis and assessment of the status of patients with COVID-19. The results obtained with frozen whole blood samples are consistent with those from plasma and serum.</AbstractText><CopyrightInformation>© 2024 Walter de Gruyter GmbH, Berlin/Boston.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bugrova</LastName><ForeName>Anna E</ForeName><Initials>AE</Initials><AffiliationInfo><Affiliation>366033 Skolkovo Institute of Science and Technology , Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emanuel Institute of Biochemical Physics, Russian Academy of Science, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strelnikova</LastName><ForeName>Polina A</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>366033 Skolkovo Institute of Science and Technology , Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Emanuel Institute of Biochemical Physics, Russian Academy of Science, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kononikhin</LastName><ForeName>Alexey S</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>366033 Skolkovo Institute of Science and Technology , Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>V.L. Talrose Institute for Energy Problems of Chemical Physics, N.N. Semenov Federal Research Center for Chemical Physics, Russian Academy of Sciences, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zakharova</LastName><ForeName>Natalia V</ForeName><Initials>NV</Initials><AffiliationInfo><Affiliation>Emanuel Institute of Biochemical Physics, Russian Academy of Science, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diyachkova</LastName><ForeName>Elizaveta O</ForeName><Initials>EO</Initials><AffiliationInfo><Affiliation>Pulmonology Scientific and Research Institute, Federal Medical and Biological Agency, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brzhozovskiy</LastName><ForeName>Alexander G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>366033 Skolkovo Institute of Science and Technology , Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Indeykina</LastName><ForeName>Maria I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Emanuel Institute of Biochemical Physics, Russian Academy of Science, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kurochkin</LastName><ForeName>Ilya N</ForeName><Initials>IN</Initials><AffiliationInfo><Affiliation>Emanuel Institute of Biochemical Physics, Russian Academy of Science, Moscow, Russia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Chemical Enzymology of the Faculty of Chemistry, Lomonosov Moscow State University, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Averyanov</LastName><ForeName>Alexander V</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Pulmonology Scientific and Research Institute, Federal Medical and Biological Agency, Moscow, Russia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nikolaev</LastName><ForeName>Evgeny N</ForeName><Initials>EN</Initials><AffiliationInfo><Affiliation>366033 Skolkovo Institute of Science and Technology , Moscow, Russia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>26</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Chem Lab Med</MedlineTA><NlmUniqueID>9806306</NlmUniqueID><ISSNLinking>1434-6621</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">blood proteomics</Keyword><Keyword MajorTopicYN="N">markers</Keyword><Keyword MajorTopicYN="N">mass spectrometry</Keyword><Keyword MajorTopicYN="N">pandemic</Keyword><Keyword MajorTopicYN="N">severity</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>26</Day><Hour>4</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>25</Day><Hour>18</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39321553</ArticleId><ArticleId IdType="doi">10.1515/cclm-2024-0800</ArticleId><ArticleId IdType="pii">cclm-2024-0800</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Geyer, PE, Holdt, LM, Teupser, D, Mann, M. Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol 2017;13:942. https://doi.org/10.15252/msb.20156297 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/msb.20156297</ArticleId></ArticleIdList></Reference><Reference><Citation>Whetton, AD, Preston, GW, Abubeker, S, Geifman, N. Proteomics and informatics for understanding phases and identifying biomarkers in COVID-19 disease. J Proteome Res 2020;19:4219–32. https://doi.org/10.1021/acs.jproteome.0c00326 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00326</ArticleId></ArticleIdList></Reference><Reference><Citation>Bikdeli, B, Madhavan, MV, Jimenez, D, Chuich, T, Dreyfus, I, Driggin, E, et al.. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol 2020;75:2950–73. https://doi.org/10.1016/j.jacc.2020.04.031 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2020.04.031</ArticleId></ArticleIdList></Reference><Reference><Citation>Teuwen, LA, Geldhof, V, Pasut, A, Carmeliet, P. COVID-19: the vasculature unleashed. Nat Rev Immunol 2020;20:389–91. https://doi.org/10.1038/s41577-020-0343-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-020-0343-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Cugno, M, Meroni, PL, Gualtierotti, R, Griffini, S, Grovetti, E, Torri, A, et al.. Complement activation in patients with COVID-19: a novel therapeutic target. J Allergy Clin Immunol 2020;146:215–17. https://doi.org/10.1016/j.jaci.2020.05.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2020.05.006</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent, JL, Taccone, FS. Understanding pathways to death in patients with COVID-19. Lancet Respir Med 2020;8:430–2. https://doi.org/10.1016/s2213-2600(20)30165-x .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2213-2600(20)30165-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermali, M, Khalsa, RK, Pillai, K, Ismail, Z, Harky, A. The role of biomarkers in diagnosis of COVID-19 – a systematic review. Life Sci 2020;254:117788. https://doi.org/10.1016/j.lfs.2020.117788 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2020.117788</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Nesf, MAY, Abdesselem, HB, Bensmail, I, Ibrahim, S, Saeed, WAH, Mohammed, SSI, et al.. Prognostic tools and candidate drugs based on plasma proteomics of patients with severe COVID-19 complications. Nat Commun 2022;13:946. https://doi.org/10.1038/s41467-022-28639-4 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-28639-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Byeon, SK, Madugundu, AK, Garapati, K, Ramarajan, MG, Saraswat, M, Kumar, MP, et al.. Development of a multiomics model for identification of predictive biomarkers for COVID-19 severity: a retrospective cohort study. Lancet Digital Health 2022;4:e632–45. https://doi.org/10.1016/s2589-7500(22)00112-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s2589-7500(22)00112-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim, WY. Multi-omic approach to identify risk markers specific to COVID-19. EBioMedicine 2022;79:104009. https://doi.org/10.1016/j.ebiom.2022.104009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.104009</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen, B, Yi, X, Sun, Y, Bi, X, Du, J, Zhang, C, et al.. Proteomic and metabolomic characterization of COVID-19 patient sera. Cell 2020;182:59–72.e15. https://doi.org/10.1016/j.cell.2020.05.032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.05.032</ArticleId></ArticleIdList></Reference><Reference><Citation>Messner, CB, Demichev, V, Wendisch, D, Kurth, F, Sander, LE, Messner, CB, et al.. Ultra-high-throughput clinical proteomics reveals classifiers of COVID-19 infection. Cell Syst 2020;11:11–24.e4. https://doi.org/10.1016/j.cels.2020.05.012 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.05.012</ArticleId></ArticleIdList></Reference><Reference><Citation>D’Alessandro, A, Thomas, T, Dzieciatkowska, M, Hill, RC, Francis, RO, Hudson, KE, et al.. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J Proteome Res 2020;19:4417–27. https://doi.org/10.1021/acs.jproteome.0c00365 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.0c00365</ArticleId></ArticleIdList></Reference><Reference><Citation>Di, B, Jia, H, Luo, OJ, Lin, F, Li, K, Zhang, Y, et al.. Identification and validation of predictive factors for progression to severe COVID-19 pneumonia by proteomics. Signal Transduction Targeted Ther 2020;5:217. https://doi.org/10.1038/s41392-020-00333-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00333-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Demichev, V, Tober-Lau, P, Lemke, O, Nazarenko, T, Thibeault, C, Whitwell, H, et al.. A time-resolved proteomic and prognostic map of COVID-19. Cell Syst 2021;12:780–94.e7. https://doi.org/10.1016/j.cels.2021.05.005 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2021.05.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu, T, Ning, W, Wu, D, Xu, J, Han, Q, Huang, M, et al.. Plasma proteomics identify biomarkers and pathogenesis of COVID-19. Immunity 2020;53:1108–22.e5. https://doi.org/10.1016/j.immuni.2020.10.008 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2020.10.008</ArticleId></ArticleIdList></Reference><Reference><Citation>Park, J, Kim, H, Kim, SY, Kim, Y, Lee, JS, Dan, K, et al.. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci Rep 2020;10:22418. https://doi.org/10.1038/s41598-020-80120-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-80120-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Geyer, PE, Arend, FM, Doll, S, Louiset, M, Virreira Winter, S, Müller‐Reif, JB, et al.. High‐resolution serum proteome trajectories in COVID‐19 reveal patient‐specific seroconversion. EMBO Mol Med 2021;13:e14167. https://doi.org/10.15252/emmm.202114167 .</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114167</ArticleId></ArticleIdList></Reference><Reference><Citation>Suvarna, K, Biswas, D, Pai, MGJ, Acharjee, A, Bankar, R, Palanivel, V, et al.. Proteomics and machine learning approaches reveal a set of prognostic markers for COVID-19 severity with drug repurposing potential. Front Physiol 2021;12:1–18. https://doi.org/10.3389/fphys.2021.652799 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2021.652799</ArticleId></ArticleIdList></Reference><Reference><Citation>Völlmy, F, van den Toorn, H, Chiozzi, RZ, Zucchetti, O, Papi, A, Volta, CA, et al.. A serum proteome signature to predict mortality in severe covid-19 patients. Life Sci Alliance 2021;4:1–12.</Citation></Reference><Reference><Citation>Wang, Z, Cryar, A, Lemke, O, Tober-Lau, P, Ludwig, D, Helbig, ET, et al.. A multiplex protein panel assay for severity prediction and outcome prognosis in patients with COVID-19: an observational multi-cohort study. eClinicalMedicine 2022;49:1–15. https://doi.org/10.1016/j.eclinm.2022.101495 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101495</ArticleId></ArticleIdList></Reference><Reference><Citation>Reverté, L, Yeregui, E, Olona, M, Gutiérrez‐Valencia, A, Buzón, MJ, Martí, A, et al.. Fetuin‐A, inter‐α‐trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes. Clin Transl Med 2022;12:e704. https://doi.org/10.1002/ctm2.704 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ctm2.704</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammed, Y, Goodlett, DR, Cheng, MP, Vinh, DC, Lee, TC, Mcgeer, A, et al.. Longitudinal plasma proteomics analysis reveals novel candidate biomarkers in acute COVID-19. J Proteome Res 2022;21:975–92. https://doi.org/10.1021/acs.jproteome.1c00863 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00863</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard, VR, Gaither, C, Popp, R, Chaplygina, D, Brzhozovskiy, A, Zahedi, P, et al.. Early prediction of COVID-19 patient survival by targeted plasma multi-omics and machine learning authors early prediction of COVID-19 patient survival by targeted plasma multi-omics and machine learning. Mol Cell Proteomics 2022;2:100277.</Citation></Reference><Reference><Citation>di Flora, DC, Dionizio, A, Pereira, HABS, Garbieri, TF, Grizzo, LT, Dionisio, TJ, et al.. Analysis of plasma proteins involved in inflammation, immune response/complement system, and blood coagulation upon admission of COVID-19 patients to hospital may help to predict the prognosis of the disease. Cells 2023;12:1601. https://doi.org/10.3390/cells12121601 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells12121601</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin, NJ, Bunch, J, Cooper, HJ. Dried blood spot proteomics: surface extraction of endogenous proteins coupled with automated sample preparation and mass spectrometry analysis. J Am Soc Mass Spectrom 2013;24:1242–9. https://doi.org/10.1007/s13361-013-0658-1 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13361-013-0658-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers, AG, Percy, AJ, Yang, J, Camenzind, AG, Borchers, CH. Multiplexed quantitation of endogenous proteins in dried blood spots by multiple reaction monitoring – mass spectrometry. Mol Cell Proteomics 2013;12:781–91. https://doi.org/10.1074/mcp.m112.022442 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.m112.022442</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosting, C, Yu, J, Cooper, HJ. High field asymmetric waveform ion mobility spectrometry in nontargeted bottom-up proteomics of dried blood spots. J Proteome Res 2018;17:7918–24. https://doi.org/10.1021/acs.jproteome.7b00746 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.7b00746</ArticleId></ArticleIdList></Reference><Reference><Citation>Molloy, MP, Hill, C, O’Rourke, MB, Chandra, J, Steffen, P, McKay, MJ, et al.. Proteomic analysis of whole blood using volumetric absorptive microsampling for precision medicine biomarker studies. J Proteome Res 2022;21:1196–203. https://doi.org/10.1021/acs.jproteome.1c00971 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00971</ArticleId></ArticleIdList></Reference><Reference><Citation>Braudeau, C, Salabert-Le Guen, N, Chevreuil, J, Rimbert, M, Martin, JC, Josien, R. An easy and reliable whole blood freezing method for flow cytometry immuno-phenotyping and functional analyses. Cytometry, Part B 2021;100:652–65.</Citation></Reference><Reference><Citation>Gaither, C, Popp, R, Mohammed, Y, Borchers, CH. Determination of the concentration range for 267 proteins from 21 lots of commercial human plasma using highly multiplexed multiple reaction monitoring mass spectrometry. Analyst 2020;145:3634–44. https://doi.org/10.1039/c9an01893j .</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c9an01893j</ArticleId></ArticleIdList></Reference><Reference><Citation>Kononikhin, AS, Zakharova, NV, Semenov, SD, Bugrova, AE, Brzhozovskiy, AG, Indeykina, MI, et al.. Prognosis of alzheimer’s disease using quantitative mass spectrometry of human blood plasma proteins and machine learning. Int J Mol Sci 2022;23:7907. https://doi.org/10.3390/ijms23147907 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23147907</ArticleId></ArticleIdList></Reference><Reference><Citation>Virtanen, P, Gommers, R, Oliphant, TE, Haberland, M, Reddy, T, Cournapeau, D, et al.. Author Correction: SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat Methods 2020;17:261–72. https://doi.org/10.1038/s41592-020-0772-5 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-020-0772-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Waskom, M. Seaborn: statistical data visualization. J Open Source Softw 2021;6:3021. https://doi.org/10.21105/joss.03021 .</Citation><ArticleIdList><ArticleId IdType="doi">10.21105/joss.03021</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunter, JD. Matplotlib: a 2D graphics environment. Comput Sci Eng 2007;9:90–5. https://doi.org/10.1109/mcse.2007.55 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1109/mcse.2007.55</ArticleId></ArticleIdList></Reference><Reference><Citation>McKinney, W. Data structures for statistical computing in Python. In: Proceedings of the 9th Python in science conference ; 2010.</Citation></Reference><Reference><Citation>Pedregosa, F, Varoquaux, G, Gramfort, A, Michel, V, Thirion, B, Grisel, O, et al.. Scikit-learn: machine learning in Python. J Mach Learn Res 2011;12:2825–30.</Citation></Reference><Reference><Citation>Whelan, SA, Hendricks, NP, Dwight, Z, Fu, Q, Moradian, A, Van, JE, et al.. Assessment of a 60-biomarker health surveillance panel (HSP) on whole blood from remote sampling devices by targeted LC/MRM-MS and discovery DIA-MS analysis. Anal Chem 2023;95:11007–18. https://doi.org/10.1021/acs.analchem.3c01189 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.analchem.3c01189</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>